-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on Pharvaris, Raises Price Target to $44

Benzinga·09/10/2026 14:17:59
Listen to the news
Guggenheim analyst Debjit Chattopadhyay maintains Pharvaris (NASDAQ:PHVS) with a Buy and raises the price target from $40 to $44.